Homoharringtonine directly binds to HSF1, and suppresses its expression and transcription of HSF1 target genes, leading to the selective inhibition of pancreatic cancer cell viability with high HSF1 expression (Table 1) 183. The gene discussed is HSF1; the disease is familial pancreatic carcinoma.